Viewing Study NCT02422992


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-01-02 @ 9:32 AM
Study NCT ID: NCT02422992
Status: COMPLETED
Last Update Posted: 2016-11-29
First Post: 2015-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Haptoglobin and Iron in Parkinson's Disease
Sponsor: Bastyr University
Organization:

Study Overview

Official Title: Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease
Status: COMPLETED
Status Verified Date: 2016-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HPPD
Brief Summary: This is a case/control epidemiology study to identify what are the iron-metabolism abnormalities in Parkinson's disease (PD) patients, and risk factors relevant to PD predisposition.
Detailed Description: A total of 342 participants, 100 PD patients and 242 age- and gender matched controls, were included in the study. All study participants were seen for one study visit in the morning at one of two Bastyr University Clinics in the Seattle area. Study participants were fasting at the time of the visit. During the study visit, participants donated a blood sample for the blood tests and complete an epidemiology questionnaire.

A subset of 51 of the study participant who were seen for the visit at Bastyr University, underwent brain scan and Magnetic Resonance Imaging (MRI), at the University of Washington Department of Radiology. The MRI part of the study aims at estimating brain iron levels.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: